Navigation Links
Eastern Clinical Trials Russia CRO Passes EMA Inspection
Date:2/12/2013

Moscow, Russia (PRWEB) February 12, 2013

Moscow, Russia January 31, 2013 -- Eastern Clinical Trials (ECT), a leading contract research organization (CRO) with operations in Russia and Central and Eastern Europe, announced today that it successfully passed with no major findings an inspection conducted by the European Medicines Agency (EMA).

The Inspection was conducted on 22-24 January 2013 at the site of Professor Sergey V. Orlov MD, PhD, of Saint Petersburg State Medical University, who is a principal investigator in a large registration oncology trial.

“We are very pleased to have passed the EMA Inspection” commented Dr. Svetlana Vodolazhskaya, Managing Director of Eastern Clinical Trials. “The Agency’s inspection results confirm that ECT's clinical research operations meet and often exceed international standards. We realize the importance of efficient operations that meet our client’s high requirements in drug development process and take great pride in both the quality of our work and in ECT's exceptional team of professionals.”

About Eastern Clinical Trials (ECT)(http://www.easterntrials.com)
Established in 2004, Eastern Clinical Trials (ECT) has grown from a local Moscow-based CRO to a trusted regional partner in clinical research with operations in Russia, Ukraine, Belarus, Georgia, Hungary and Slovakia. ECT provides a full spectrum of clinical trial services including project management, monitoring, study feasibility, regulatory submission and support, translation, safety reporting and warehousing.

Contact:
Svetlana Vodolazhskaya, MD
Managing Director
Russia 119034 Moscow
Tel: + 7(925)5023189
svetlana.vodolazhskaya(at)easterntrials(dot)com

Read the full story at http://www.prweb.com/releases/2013/2/prweb10421281.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Northeastern University Nanomanufacturing Center Director Ahmed Busnaina to Present Webinar on “The Democratization of Manufacturing”
2. Reminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time
3. ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188
4. Galectin-3 Assessed as a Biomarker of Heart Failure: Key Clinical Trial Findings Published by Dove Medical Press
5. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
6. Cutting the Cost of Clinical Research: The Solution Comes from Russia, New Xtalks Webinar
7. OpenClinica to Exhibit at SCOPE (Summit for Clinical Ops Executives)
8. Infinata's BioPharm Clinical™ to Present Session on Improving Investigator Selection at CHI’s Summit for Clinical Operations (SCOPE) on February 6 in Miami, FL
9. Migraines Found Linked to Nighttime Teeth Grinding & Clenching in TMJ Treatment Clinical Trial - Holistic Technologies
10. MC Leeuwarden Selects ClinicalKey
11. ComplianceOnline Announces Seminar on Clinical Trial Project Supplier Quality Improvement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):